Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Steroid Biochem Mol Biol ; 101(2-3): 145-50, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16890426

ABSTRACT

17beta-Hydroxysteroid dehydrogenase (17beta-HSD) Type3 is an NADPH-dependent membrane-bound enzyme that is specifically expressed in testis and catalyzes the conversion of androstenedione to testosterone. To date, the sequence of Type3 enzymes has been clarified in humans, mice and rats; however, the sequence of the pig enzyme remains unknown. In this study, we determined the cDNA sequence of pig testicular 17beta-HSD Type3. PCR primers for partial pig testicular 17beta-HSD Type3 were designed from rat and human enzyme consensus sequences. Full-length cDNA was obtained by 3'- and 5'-RACE based on partial PCR products. The cDNA coding region was 933 bp in length, which is the same as the human enzyme, and shared 84.7% sequence identity with the human cDNA coding region. The monomer was estimated to have a molecular weight of 34,855 and to contain 310 amino acid residues. The predicted pig amino acid sequence showed 81.9, 75.5 and 72.9% sequence identity with the human, rat and mouse sequences, respectively. To elucidate 17beta-HSD Type3 activity, the expression vector pCMV/pig17beta-HSD3 was established and transfected into human embryo kidney 293 cells. Subsequently, 17beta-HSD activity (androstenedione conversion to testosterone) was strongly detected in cell lysates.


Subject(s)
17-Hydroxysteroid Dehydrogenases/genetics , 17-Hydroxysteroid Dehydrogenases/metabolism , Swine/metabolism , Testis/enzymology , Amino Acid Sequence , Animals , Base Sequence , Cell Line , DNA, Complementary , Gene Expression , Humans , Male , Molecular Sequence Data , RNA, Messenger/metabolism , Transfection
2.
Steroids ; 70(9): 645-51, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15899506

ABSTRACT

We previously reported that tributyltin chloride (TBT) and triphenyltin chloride (TPT) powerfully suppressed human chorionic gonadotropin- and 8-bromo-cAMP-stimulated testosterone production in pig Leydig cells at concentrations that were not cytotoxic [Nakajima Y, Sato Q, Ohno S, Nakajin S. Organotin compounds suppress testosterone production in Leydig cells from neonatal pig testes. J Health Sci 2003;49:514-9]. This study investigated the effects of these organotin compounds on the activity of enzymes involved in testosterone biosynthesis in pig testis. At relatively low concentrations of TPT, 17beta-hydroxysteroid dehydrogenase (17beta-HSD; IC(50)=2.6microM) and cytochrome P450 17alpha-hydroxylase/C(17-20) lyase (IC(50)=117microM) activities were inhibited, whereas cholesterol side-chain cleavage cytochrome P450 and 3beta-HSD/Delta(4)-Delta(5) isomerase activities were less sensitive. Overall, TPT was more effective than TBT. TPT also inhibited both ferredoxin reductase and P450 reductase activities at concentrations over 30microM; however, TBT had no effect, even at 100microM. The IC(50) values of TPT were estimated to be 25.7 and 22.8microM for ferredoxin reductase and P450 reductase, respectively. The inhibitory effect of TPT (30microM) on microsomal 17beta-HSD activity from pig testis was eliminated by pretreatment with the reducing agents dithiothreitol (1mM) and dithioerythritol (1mM). On the other hand, TPT (0.03microM) or TBT (0.1microM) exposure suppressed the testosterone production from androstenedione in pig Leydig cells indicating that these organotins inhibit 17beta-HSD activity in vivo as well as in vitro, and the IC(50) values of TPT and TBT for 17beta-HSD activity were estimated to be 48 and 114nM, respectively. Based on these results, it appears possible that the effects of TBT and TPT are largely due to direct inhibition of 17beta-HSD activity in vivo.


Subject(s)
17-Hydroxysteroid Dehydrogenases/antagonists & inhibitors , Organotin Compounds/pharmacology , Testis/drug effects , Testosterone/biosynthesis , Trialkyltin Compounds/pharmacology , 17-Hydroxysteroid Dehydrogenases/metabolism , Animals , Animals, Newborn , Cholesterol Side-Chain Cleavage Enzyme/antagonists & inhibitors , Cholesterol Side-Chain Cleavage Enzyme/metabolism , Dithioerythritol/pharmacology , Dithiothreitol/pharmacology , Dose-Response Relationship, Drug , Ferredoxin-NADP Reductase/antagonists & inhibitors , Leydig Cells/drug effects , Leydig Cells/enzymology , Male , Microsomes/drug effects , Microsomes/enzymology , Mitochondria/drug effects , Mitochondria/enzymology , NADPH-Ferrihemoprotein Reductase/antagonists & inhibitors , Steroid 17-alpha-Hydroxylase/antagonists & inhibitors , Steroid 17-alpha-Hydroxylase/metabolism , Swine , Testis/metabolism
3.
Environ Toxicol Pharmacol ; 20(1): 11-7, 2005 Jul.
Article in English | MEDLINE | ID: mdl-21783561

ABSTRACT

We previously reported that organotin compounds, such as tributyltin chloride (TBT), dibutyltin dichloride and triphenyltin chloride, strongly suppressed the testosterone production level in isolated neonatal pig testicular Leydig cells at a concentration without cytotoxicity. In this report, the action mechanisms of suppressive effect of the testosterone production by TBT were investigated. TBT (0.1µM) exposure to pig Leydig cells for 4h significantly decreased the intracellular cAMP level stimulated by human chorionic gonadotropin (hCG; 10IU/ml) and also the level stimulated by forskolin (25µM). In the same way, TBT exposure for 6 and 24h significantly decreased the 17α-hydroxylase/17,20-lyase (P450cl7) mRNA level stimulated by hCG. However, TBT exposure did not affect the mRNA levels of other steroidogenic enzymes, such as cholesterol side chain cleavage enzyme, 3ß-hydroxysteroid dehydrogenase/Δ(4)-Δ(5) isomerase, 17ß-hydroxysteroid dehydrogenase, and steroidogenic acute regulatory protein, estimated by RT-PCR. These results suggest that TBT exposure inhibits the adenyl cyclase activity of Leydig cells, which in turn suppresses testosterone production due to a decrease in the P450cl7 transcription level induced by decreasing intracellular cAMP levels.

4.
Life Sci ; 74(6): 733-42, 2003 Dec 26.
Article in English | MEDLINE | ID: mdl-14654166

ABSTRACT

The phytochemical flavonoid genistein has been shown to act as a potent competitive inhibitor of human adrenocortical 3beta-hydroxysteroid dehydrogenase and cytochrome P450 21-hydroxylase activities in vitro [J. Steroid Biochem. Molec. Biol. 2002; 80: 355-363]. In the present study, we evaluated the effects of large amounts of genistein continuously administered to weanling rats, particularly on steroidogenesis at the pubertal stage in vivo. Serum concentrations of free and total genistein were significantly higher in the 40 mg/kg genistein administration group when compared with the control group. In genistein administered rats, adrenal weight was significantly higher. Furthermore, a clear expansion of cells was observed in hematoxylin and eosin stained tissue at the zona fasciculata and zona reticularis of the adrenal cortex. However in the testis, no differences in weights or histologic changes were observed. Serum corticosterone concentration significantly decreased to 50% of control levels by 40 mg/kg genistein administration and testosterone also tended to decrease with this dose of genistein. On the other hand, although serum follicle stimulating hormone was unchanged, adrenocorticotropic hormone and luteinizing hormone levels increased with genistein administration. These results suggest a significant effect of genistein on steroidogenesis in the adrenal gland and testis of rats, and this effect appeared to be more evident on steroid production in adrenals than in testis in vivo.


Subject(s)
Adrenal Glands/drug effects , Corticosterone/blood , Enzyme Inhibitors/pharmacology , Genistein/pharmacology , Testosterone/blood , Adrenal Glands/metabolism , Adrenal Glands/pathology , Adrenocorticotropic Hormone/blood , Animals , Cell Division/drug effects , Dose-Response Relationship, Drug , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/blood , Follicle Stimulating Hormone/blood , Genistein/administration & dosage , Genistein/blood , Injections, Subcutaneous , Luteinizing Hormone/blood , Male , Organ Size/drug effects , Prostate/drug effects , Prostate/pathology , Rats , Rats, Wistar , Testis/drug effects , Testis/metabolism , Testis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL